The value of endoscopic healing index monitoring for guiding infliximab dosing in patients with Crohn's disease

被引：0
|
作者：
Kantasiripitak, W.
Mathot, R.
Oldenburg, B.
Buisson, A.
Ferrante, M.
Laharie, D.
D'Haens, C.
Vermeire, S.
Dreesen, E.
机构：
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.620
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P497
引用
收藏
页码：S481 / S482
页数：3
相关论文
共 50 条
  • [31] Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn's disease
    Zhu, Kouzhu
    Ding, Xiaoliang
    Xue, Ling
    Liu, Linsheng
    Wang, Yan
    Li, Yun
    Xi, Qinhua
    Pang, Xueqin
    Chen, Weichang
    Miao, Liyan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [32] Subcutaneous Infliximab Concentration Thresholds for Mucosal and Transmural Healing in Patients With Crohn's Disease
    Hong, Sung Noh
    Song, Joo Hye
    Kim, Sung Jin
    Park, Yoon Ha
    Choi, Chang Wan
    Kim, Ji Eun
    Kim, Eun Ran
    Chang, Dong Kyung
    Kim, Young-Ho
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (02) : 313 - 322
  • [33] Factors Associated with Development of Endoscopic Stricture in Patients with Crohn's Disease Treated with Infliximab
    Feng, T.
    Chen, B. -I.
    Mao, R.
    Li, M.
    Rao, P.
    Zeng, Z. -R.
    Hu, P.
    Chen, M. -H.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S318 - S319
  • [34] Complete Endoscopic Healing Associated With Better Outcomes Than Partial Endoscopic Healing in Patients With Crohn's Disease
    Yzet, Clara
    Diouf, Momar
    Le Mouel, Jean-Philippe
    Brazier, Franck
    Turpin, Justine
    Loreau, Julien
    Dupas, Jean Louis
    Peyrin-Biroulet, Laurent
    Fumery, Mathurin
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (10) : 2256 - 2261
  • [35] Desensitisation to infliximab in patients with Crohn's disease
    Lelong, J
    Duburque, C
    Fournier, C
    Colombel, JF
    Desreumaux, P
    Tonnel, AB
    Wallaert, B
    REVUE DES MALADIES RESPIRATOIRES, 2005, 22 (02) : 239 - 246
  • [36] Endoscopic and Mucosal Healing in Crohn's Disease with Azathioprine
    Nadir, Isilay
    Kafadar, Mehmet Tolga
    Kasapoglu, Benan
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2016, 7
  • [37] Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease
    Steenholdt, Casper
    Ainsworth, Mark A.
    Tovey, Michael
    Klausen, Tobias W.
    Thomsen, Ole O.
    Brynskov, Jorn
    Bendtzen, Klaus
    THERAPEUTIC DRUG MONITORING, 2013, 35 (04) : 530 - 538
  • [38] Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease
    Danese, Silvio
    Sandborn, William J.
    Colombel, Jean-Frederic
    Vermeire, Severine
    Glover, Sarah C.
    Rimola, Jordi
    Siegelman, Jenifer
    Jones, Stephen
    Bornstein, Jeffrey D.
    Feagan, Brian G.
    GASTROENTEROLOGY, 2019, 157 (04) : 1007 - +
  • [39] The Crohn's disease endoscopic score (CDES) is a simple index to assess endoscopic severity of Crohn's disease
    Daperno, M
    Van Assche, G
    Gevers, AM
    Baert, F
    Pera, A
    D'Haens, G
    Rutgeerts, P
    GASTROENTEROLOGY, 2002, 122 (04) : A216 - A216
  • [40] Stability of Infliximab dosing in Crohn's disease: Results from a Chart Review
    Waters, H.
    McKenzie, R.
    Lunacsek, O.
    Franklin, M.
    Lennert, B.
    Piech, C.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S19 - S20
12345